Novo Nordisk, headquartered in Copenhagen, has seen its shares surge by more than 6 per cent after unveiling promising results from a late-stage clinical trial of its new anti-obesity tablet.
All posts tagged in clinical trials
13Articles
A leading biopharmaceutical business saw its shares tumble by almost 40 per cent after results from a trial of its much-anticipated weight loss pill failed to meet market expectations. Viking
The UK government’s recently unveiled life sciences sector plan has faced sharp criticism from industry leaders for failing to address key concerns about investment in innovative medicines. The 78-page strategy,
The first clinical trial investigating whether psilocybin, the psychedelic compound found in magic mushrooms, could treat Parkinson’s disease has yielded promising early-stage results. Scientists have described the findings as both
The American pharmaceutical giant Pfizer has discontinued the development of its experimental weight-loss pill following safety concerns, marking a significant setback in its pursuit of the lucrative anti-obesity market, estimated
Research suggests that thousands of lives could be saved and subsequent heart attacks or strokes prevented through the administration of two cost-effective medicines. The study, conducted jointly by Imperial College
UK Government Accelerates Clinical Trials and Improves Access to NHS Data The United Kingdom government has unveiled ambitious plans aimed at enhancing the speed of clinical trials and facilitating greater
A groundbreaking clinical trial at University College London (UCL) is poising to transform the landscape of alcohol misuse treatment through the utilisation of dimethyltryptamine (DMT), a potent psychedelic compound. The
Danish pharmaceutical giant Novo Nordisk witnessed a staggering $100 billion erosion in market value following disappointing results from its latest obesity drug trial. The company’s shares experienced their most significant
A significant move in the pharmaceutical investment landscape has emerged as Carlyle-backed Abingworth seeks to raise up to £1.5 billion for clinical trials funding, marking a strategic shift towards royalty-based
A revolutionary combination of three drugs has demonstrated remarkable success in doubling survival times for patients battling incurable breast cancer, according to a landmark clinical trial. The research, spearheaded by
In a significant development in the fight against lung cancer, doctors have initiated the world’s first mRNA lung cancer vaccine trials in patients across seven countries. This pioneering jab, known
Imaging Biometrics, a subsidiary of IQ-AI Ltd, has recently made a significant announcement regarding its lead drug candidate, IB-003. The US Food and Drug Administration (FDA) has granted Rare Pediatric
